Study-related adverse events In a 26-week, open-label study in adult patients (N=665) comparing Victoza 1.2 mg, Victoza 1.8 mg, and sitagliptin 100 mg, all in combination with metformin, the adverse reactions reported in 5% of patients treated with Victoza were nausea (23.9% vs 4.6%), headache (10.3% vs 10.0%), diarrhea (9.3% vs 4.6%), and vomiting (8.7% vs 4.1%)
The study followed 30 patients with obesity and HS (27 females, 3 males, average age 42) from June 2020 to March 2023
Our medical weight loss clinic provides a comprehensive weight loss method involving FDA-approved weight loss medications, a healthy diet, physical exercise, and lifestyle changes that can help you lose weight
Bioequivalence study of two multivitamin formulations containing vitamin E and folate in healthy adults